Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011
about
Population-based epidemiology and microbiology of community-onset bloodstream infectionsWorrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year periodSurveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage.Secular Trends in Utilization of Critical Care Services Among Candidemia-Associated Hospitalizations: A Population-Based Cohort Study.Temporal Trends of the Clinical, Resource Use and Outcome Attributes of ICU-Managed Candidemia Hospitalizations: A Population-Level Analysis.Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.Invasive fungal infections in the ICU: how to approach, how to treat.Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014.Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Effects of the Global Financial Crisis on Health in High-Income Oecd Countries: A Narrative Review.The Changing Epidemiology of Invasive Fungal Infections.β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin.Clinical and microbiological investigation of fungemia from four hospitals in China.Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.Increasing candidemia incidence from 2004 to 2015 with a shift in epidemiology in patients pre-exposed to antifungals.Prevalent drug resistance among oral yeasts from asymptomatic patients in Hainan, China.Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey.Update from a twelve-year nationwide fungaemia surveillance: increasing intrinsic and acquired resistance causes concern.Changes in the epidemiological landscape of invasive candidiasis.Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries.Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.
P2860
Q27013639-51003FC1-12A7-4E29-8236-2369770591BBQ34100598-17162534-FC13-4D48-8A60-E400B1370EC3Q34252030-1946BBA7-DD4F-4AFD-A12A-0EE199F6902EQ34856747-A45837F6-081F-4AF2-A0DD-58BCBF3A83B6Q35097956-2402B9BB-83EC-4BCD-9E8E-623EC2E2DB2BQ35112435-010FCD03-9FF5-45BB-84B1-F504D036DEC8Q36364768-83ACEB24-EEF1-4E32-8691-37227153F57CQ36658546-77148ABB-7381-4802-97A5-2FFD59C45B79Q36933437-F6403E46-A655-41FB-A29E-3DB8BD5393C2Q38180287-D11CADB4-925A-4571-ADD0-78C4115C2ABDQ38233262-876847E4-2D87-4537-B975-0CAF63ED4DC1Q38606963-533B4C18-D6DF-4549-BE67-524D47BA9C78Q38711698-9E77E109-9154-4791-BC3C-6F378502C363Q38807927-CCF24B8E-DBBF-41E9-9140-0A03E7AD0609Q40454886-00CABB3D-F818-4BD6-9841-51545CD27F0FQ40819010-21558E0D-98CD-434B-A8D1-AD646EECE561Q41462402-D9185A1E-CE06-41D1-AC8A-B768E991441AQ41613426-2591692C-8767-43DC-9920-95D268064EF6Q41986535-EAB8AEDC-FFF0-47B0-8532-A831055C1979Q42215771-BF76E973-1A53-443D-9317-8C2E9076B64BQ46862646-209F500B-B079-46D7-BD3E-83B285393F95Q47355716-4B20DED8-3D1A-40BC-911F-E0EB695CC519Q47749844-EC28BE90-41E1-4A3B-9CBF-7BF2BEF78817Q48163160-8880766E-C9DD-493F-92B5-034159C0EE12Q48523172-BAAAB765-BF39-4AF2-998C-DEEE30C196DEQ54943425-7C33814B-7608-4A7A-8447-EB6D4C0B09E0
P2860
Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@ast
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@en
type
label
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@ast
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@en
prefLabel
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@ast
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@en
P2860
P356
P1476
Nationwide study of candidemia ...... tance in Iceland, 2000 to 2011
@en
P2093
Helga Erlendsdottir
Lena Ros Asmundsdottir
P2860
P304
P356
10.1128/JCM.02566-12
P407
P577
2012-12-26T00:00:00Z